Lateral flow test data shows potential for companion diagnostic to the Pfizer-BioNTech COVID-19 vaccine
AbC-19TM rapid antibody test was effective in demonstrating immune response following first dose vaccination
Omega (AIM: ODX), the medical diagnostics company focused on CD4, infectious diseases and food intolerance, notes the press release issued today by the UK Rapid Test Consortium (“UK-RTC”), of which Omega is a partner, which presents new data relating to the performance of the AbC-19TM rapid antibody test when used as a companion diagnostic to the Pfizer-BioNTech COVID-19 vaccine. The initial study performed at the University of Birmingham highlighted the effectiveness of the AbC-19TM rapid antibody test in demonstrating immune response following vaccination.
During the study t he AbC-19™ Rapid Test was used to test individuals who had been given a single dose of the Pfizer-BioNTech COVID-19 vaccine. In total 193 individuals who had received a COVID-19 vaccine were tested for the presence of IgG antibodies to the full trimeric spike using the AbC-19TM test. Of these individuals, a sub-set of 65 patients had been determined to have previously been infected with COVID-19, and 128 had no previous infection. The study also concluded that patients previously infected with COVID-19 showed a stronger immune response to the first dose of the Pfizer-BioNTech COVID-19 vaccine.
Following the study the statement from the UK-RTC said:
“The initial data from the study being performed at the University of Birmingham supports the rationale that vaccination programmes could benefit from determining an individual’s antibody status not only after vaccination but also prior to vaccination. Should these results continue to be seen in further studies, and with other vaccines, this demonstrates that the AbC-19 TM antibody test could potentially assist in patient stratification and resource management in overburdened international healthcare settings.”
The UK-RTC press release is reproduced in full at the end of the statement and can be found here:
https://www.abc19.com/
